Skip To The Main Content
David A. Sneider
 

David A. Sneider

Partner
 
41st Floor 9-10, Roppongi 1-Chome
Ark Hills Sengokuyama Mori Tower
Minato-Ku, Tokyo 106-0032 JP
 
Email:
Phone: +81-3-5562-6200
Fax: +81-3-5562-6202
David Sneider is a leading authority on cross-border transactions involving Japan. Major U.S. and Japanese corporations and financial institutions turn to David for guidance on M&A and capital markets transactions, and he has advised on many prominent global IPOs by Japanese issuers as well as a broad range of debt, equity and hybrid capital securities offerings. David, who is fluent in Japanese, has represented the Firm in Tokyo since 1994 and has helped establish Simpson Thacher’s Japan Practice as a leader among international law firms. In addition to his law practice, David is a Commissioner of the Japan-United States Friendship Commission.

Read Full Biography...

Work Highlights
  • KKR in its sale of Kokusai Electric to Applied Materials 
  • KKR’s acquisitions of Calsonic Kansei, Hitachi Kokusai Electric and Hitachi Koki
  • Calsonic Kansei in its acquisition of Magneti Marelli
  • KKR in its acquisition of Panasonic Healthcare for approximately ¥165 billion ($1.67 billion) and Panasonic Healthcare's subsequent acquisition of the diabetes care business of Bayer
Accolades
  • Legal Media Group’s The Best of the Best
  • International Financial Law Review’s Guide to the World’s Leading M&A Lawyers
  • Euromoney’s Guide to the World’s Leading Capital Markets Lawyers
  • Legal 500 Asia Pacific: Hall of Fame in Corporate M&A: International Firms and Joint Ventures
  • Asia Law’s Guide to Asia’s Leading Lawyers
Education
  • Harvard Law School, 1984 J.D.
    cum laude
  • University of Tokyo, 1980
  • Yale University, 1979 B.A.
    summa cum laude; Phi Beta Kappa
Associations
  • American Bar Association
Admissions
  • New York 1985

David A. Sneider is a Partner at Simpson Thacher & Bartlett LLP in the Firm’s Corporate Department. David advises both Japanese and multinational clients in cross-border transactions involving Japan, with a focus on mergers and acquisitions and capital markets transactions. His clients include many of the leading Japanese and U.S. financial institutions in Tokyo. 

David has been ranked as one of the leading U.S. corporate finance lawyers in transactions related to Japan in a number of recent surveys, including Legal Media Group’s The Best of the Best, International Financial Law Review’s Guide to the World’s Leading M&A Lawyers, Euromoney’s Guide to the World’s Leading Capital Markets Lawyers, Legal 500 Asia Pacific, Asia Law’s Guide to Asia’s Leading Lawyers and Global Counsel 3000. He was named International Dealmaker of the Year for Japan by Asia Legal Business in 2005 and 2006. Chambers Guide to the World’s Leading Lawyers included David among its “Global 100 Lawyers in 2000. He was also appointed to Japanese Government Study Group in reviewing fair M&A procedures in Japan in 2018. 

David was appointed in 2014 as a Commissioner of the Japan-United States Friendship Commission, an independent U.S. federal agency established by Congress in 1975 to strengthen the U.S.-Japan relationship through educational, cultural and intellectual exchange.

David joined Simpson Thacher in 1992 and became a Partner in 1994. He received his B.A., summa cum laude, from Yale University in 1979, where he was elected Phi Beta Kappa, and his J.D., cum laude, from Harvard Law School in 1984. He also studied at Tokyo University from 1979 to 1980.

David’s recent representative M&A transactions include representing:   

  • KKR in its sale of Kokusai Electric to Applied Materials 
  • KKR’s acquisitions of Calsonic Kansei, Hitachi Kokusai Electric and Hitachi Koki
  • KKR in its acquisition of Panasonic Healthcare for approximately ¥165 billion ($1.67 billion) and Panasonic Healthcare's subsequent acquisition of the diabetes care business of Bayer
  • Calsonic Kansei (wholly owned portfolio company by KKR) in its acquisition of Magneti Marelli for US$7.1 billion 

David’s experience in global IPOs by Japanese issuers includes representing:

  • Underwriters in Japan Airlines ¥663 billion (approximately $8.5 billion) IPO on the Tokyo Stock Exchange and global offering, the second largest IPO globally in 2012
  • Sony Financial Holdings in its ¥320 billion IPO on the Tokyo Stock Exchange and global offering
  • Universal Studios Japan in its ¥28 billion IPO and listing on the Tokyo Stock Exchange and global offering 
  • SUMCO Corporation in its ¥144 billion IPO and listing on the Tokyo Stock Exchange and global offering
  • Elpida Memory, Inc. in its ¥102 billion IPO on the Tokyo Stock Exchange and Reg S/Rule 144A offering of common stock
  • Daido Life Insurance in its ¥161.5 billion IPO on the Tokyo Stock Exchange and global offering
  • Underwriters led by Nomura Securities and UBS Limited in the ¥375 billion IPO on the Tokyo Stock Exchange and global offering by Electric Power Development Co., Ltd. (J-Power)
  • Underwriters led by Daiwa Securities SMBC, Goldman Sachs, Nikko Citigroup and Nomura Securities in the ¥160 billion IPO on the Tokyo Stock Exchange and global offering by INPEX Corporation

News & Events

    Publications